These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8307630

  • 1. Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery.
    Zimmerman RS, Maymind M, Barbee RW.
    Hypertension; 1994 Feb; 23(2):205-10. PubMed ID: 8307630
    [Abstract] [Full Text] [Related]

  • 2. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin.
    Gulati A, Sharma AC, Singh G.
    Crit Care Med; 1996 Jan; 24(1):137-47. PubMed ID: 8565519
    [Abstract] [Full Text] [Related]

  • 3. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
    Allcock GH, Warner TD, Vane JR.
    Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
    [Abstract] [Full Text] [Related]

  • 4. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men.
    Strachan FE, Spratt JC, Wilkinson IB, Johnston NR, Gray GA, Webb DJ.
    Hypertension; 1999 Jan; 33(1 Pt 2):581-5. PubMed ID: 9931169
    [Abstract] [Full Text] [Related]

  • 5. Decompensation characterized by decreased perfusion of the heart and brain during hemorrhagic shock: role of endothelin-1.
    Sharma AC, Singh G, Gulati A.
    J Trauma; 2002 Sep; 53(3):531-6. PubMed ID: 12352492
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC, Goddard J, Patel N, Strachan FE, Rankin AJ, Webb DJ.
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat.
    Bigaud M, Pelton JT.
    Br J Pharmacol; 1992 Dec; 107(4):912-8. PubMed ID: 1467841
    [Abstract] [Full Text] [Related]

  • 11. Cardiac and regional haemodynamic effects of endothelin-1 in rats subjected to critical haemorrhagic hypotension.
    Jochem J, Zwirska-Korczala K, Gwóźdź B, Walichiewicz P, Jośko J.
    J Physiol Pharmacol; 2003 Sep; 54(3):383-96. PubMed ID: 14566077
    [Abstract] [Full Text] [Related]

  • 12. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart.
    Sakai S, Miyauchi T, Sakurai T, Kasuya Y, Ihara M, Yamaguchi I, Goto K, Sugishita Y.
    Circulation; 1996 Mar 15; 93(6):1214-22. PubMed ID: 8653844
    [Abstract] [Full Text] [Related]

  • 13. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
    McMahon EG, Palomo MA, Brown MA, Bertenshaw SR, Carter JS.
    Am J Hypertens; 1993 Aug 15; 6(8):667-73. PubMed ID: 8217029
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Actions of endogenous endothelin on glomerular hemodynamics in the rat.
    Qiu C, Samsell L, Baylis C.
    Am J Physiol; 1995 Aug 15; 269(2 Pt 2):R469-73. PubMed ID: 7653672
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses.
    Douglas SA, Elliott JD, Ohlstein EH.
    Eur J Pharmacol; 1992 Oct 20; 221(2-3):315-24. PubMed ID: 1426008
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
    Allcock GH, Warner TD.
    J Cardiovasc Pharmacol; 1995 Oct 20; 26 Suppl 3():S177-9. PubMed ID: 8587355
    [Abstract] [Full Text] [Related]

  • 20. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P.
    Scand Cardiovasc J Suppl; 1997 Oct 20; 46():1-40. PubMed ID: 9265559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.